Tag: covid
-
Airpop Announces Latest Product, The Active+ Smart Mask With Halo Sensor
AirPop, which was founded in 2015, is the world’s first Air Wearables company. The company has harnessed filtration science and technology to build high-performance products that deliver unrivalled comfort and breathability. Airpop has announced the launch of its latest innovative product and it’s going to help us all get through lockdown. It’s called The Active+…
-
Are Beauty Salons Open Under New Tier 3 Restrictions?
As of 2nd December 2020, England officially came out of its second lockdown. The British Prime Minister made clear, that after the second lockdown, each county would be put under a different tier to manage their local areas infection rates. However, there is a little bit of confusion for residents and business a like to…
-
With Beauty Salons To Close Yet Again, What Does The Second National Lockdown Mean For Your Beauty Appointments?
On Saturday evening Prime Minister Boris Johnson once again addressed the nation to explain that we haven’t done enough to curb this pandemic. As a consequence he is proposing a new national lockdown which will see the closure of all non-essential shops including all related to the beauty industry. On Wednesday Parliament will vote on…
-
Covid-19 Experimental Vaccine Hopes Are Increased
A Chinese state-owned enterprise, Sinopharm, published results in the Lancet that suggest the jab they developed is safe and can produce an immune response. 600 healthy adults were given Sinopharm’s jab, dubbed BBIBP, and none suffered an adverse reaction. Every volunteer given a double-dose of Sinopharm’s vaccine made antibodies against SARS-CoV-2, the coronavirus that causes Covid-19. It was…
-
Scientists To Infect 24 People With A Weakened Version Of The Coronavirus To Develop Vaccine
Up to two dozen people in Britain could be deliberately infected with a weakened form of coronavirus as part of a trial to develop a vaccine against Covid-19. Codagenix, a New York based company, plans to begin experiments of its vaccine in London by the end of the year. The vaccine is likely to be trialled at a 24-bed…